Independent Director's 2025 Annual Performance Report
To the Shareholders and Representatives:
As an independent director of Shenzhen Haipu Rui Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), during my term of office in 2025, I strictly followed the provisions of the "Company Law," the "Administrative Measures for Independent Directors of Listed Companies," the "Work System for Independent Directors," the "Articles of Association," and other relevant laws and regulations. I attended relevant meetings, carefully reviewed various proposals, and faithfully and diligently performed my duties as an independent director, effectively safeguarding the legitimate rights and interests of the Company and its shareholders, especially small and medium shareholders. The following is a brief report of my work in 2025:
Basic Information of Independent Director
I am Lu Chuan, a Chinese national (Hong Kong) with a Ph.D. in Management. I previously served as an assistant engineer at Nanjing Jinling Shipyard Co., Ltd., an investment banking researcher at Shenzhen Nonferrous Metals Finance Co., Ltd., assistant general manager and deputy general manager of Silver Construction International Holdings Limited, director of Shenzhen Qingshan Interactive Network Co., Ltd., non-executive director of China Geothermal Energy Development Group Co., Ltd., non-executive director of E-Dargut Holdings Limited, and director of Ningxia Hao Wang Liquor Co., Ltd. Since October 2019, I have served as the Vice President of Xingye Alloy Materials Group Co., Ltd. From December 2019 to December 2025, I served as an independent director of the Company.